- Home
- PTIX vs MULN Comparison
PTIX vs MULN Comparison
Compare PTIX & MULN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTIX
- MULN
- Stock Information
- Founded
- PTIX 1994
- MULN 2014
- Country
- PTIX United States
- MULN United States
- Employees
- PTIX N/A
- MULN N/A
- Industry
- PTIX Biotechnology: Pharmaceutical Preparations
- MULN Auto Manufacturing
- Sector
- PTIX Health Care
- MULN Consumer Discretionary
- Exchange
- PTIX Nasdaq
- MULN Nasdaq
- Market Cap
- PTIX 3.9M
- MULN 4.1M
- IPO Year
- PTIX 2016
- MULN N/A
- Fundamental
- Price
- PTIX $0.64
- MULN $2.54
- Analyst Decision
- PTIX
- MULN
- Analyst Count
- PTIX 0
- MULN 0
- Target Price
- PTIX N/A
- MULN N/A
- AVG Volume (30 Days)
- PTIX 247.6K
- MULN 5.6M
- Earning Date
- PTIX 11-29-2024
- MULN 08-12-2024
- Dividend Yield
- PTIX N/A
- MULN N/A
- EPS Growth
- PTIX N/A
- MULN N/A
- EPS
- PTIX N/A
- MULN N/A
- Revenue
- PTIX N/A
- MULN $156,570.00
- Revenue This Year
- PTIX N/A
- MULN N/A
- Revenue Next Year
- PTIX N/A
- MULN N/A
- P/E Ratio
- PTIX N/A
- MULN N/A
- Revenue Growth
- PTIX N/A
- MULN N/A
- 52 Week Low
- PTIX $0.49
- MULN $1.60
- 52 Week High
- PTIX $1.87
- MULN $2,100.00
- Technical
- Relative Strength Index (RSI)
- PTIX 49.61
- MULN 37.23
- Support Level
- PTIX $0.52
- MULN $1.60
- Resistance Level
- PTIX $1.09
- MULN $3.68
- Average True Range (ATR)
- PTIX 0.15
- MULN 0.47
- MACD
- PTIX 0.01
- MULN 0.72
- Stochastic Oscillator
- PTIX 20.91
- MULN 45.19
About PTIX Protagenic Therapeutics Inc.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.
About MULN Mullen Automotive Inc.
Mullen Automotive Inc is engaged in manufacturing electric vehicles and energy solutions. The company strives to make electric vehicles more accessible by building an end-to-end ecosystem that takes care of all aspects of electric vehicle ownership. The Company owns and partners with several synergistic businesses, all working towards the same goal of creating clean and scalable electric vehicles and energy solutions. The company has two segments Bollinger and Mullen/ELMS, which generates revenue.